BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry
NCT04555174 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 872
Last updated 2024-06-21
Summary
The BIOFLOW-VIII registry is a post-market clinical evaluation of the Orsiro Mission stent in subjects requiring coronary revascularization with Drug Eluting Stents (DES).
Conditions
- Coronary Artery Disease
- Myocardial Ischemia
Interventions
- DEVICE
-
Orsiro Mission DES
Percutaneous Coronary Intervention (PCI)
Sponsors & Collaborators
-
Biotronik France
collaborator INDUSTRY -
Biotronik AG
lead INDUSTRY
Principal Investigators
-
Paul Barragan, MD · Polyclinique les Fleurs
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-25
- Primary Completion
- 2023-01-18
- Completion
- 2027-02-19
Countries
- France
Study Locations
More Related Trials
-
BIOFLOW-SV All Comers Registry
NCT03600948 ·Status: TERMINATED
-
BIOFLOW-III Austria Satellite Registry
NCT01667016 ·Status: COMPLETED
-
BIOFLOW-III Romania Satellite Registry
NCT01593059 ·Status: TERMINATED
-
BIOFLOW III Satellite-ELADIS Orsiro Stent System
NCT02029092 ·Status: COMPLETED
-
Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent
NCT01939249 ·Status: UNKNOWN ·Phase: NA
-
BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions
NCT01426139 ·Status: COMPLETED ·Phase: NA
-
BIOFLOW-III Canada Satellite Registry
NCT01880242 ·Status: COMPLETED
-
BIOFLOW-SV Portugal Registry
NCT03600961 ·Status: TERMINATED
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT02389946 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT04175626 ·Status: COMPLETED
-
Study of the Orsiro Drug Eluting Stent System
NCT01356888 ·Status: UNKNOWN ·Phase: NA
-
BIOTRONIK Orsiro Pre-Marketing Registration
NCT02870985 ·Status: COMPLETED ·Phase: NA
-
Italian Multi-center Registry of Self-apposing Coronary Stent in Patients With STEMI
NCT02979236 ·Status: UNKNOWN
-
Asian Registry of the BioFreedom Stent for STEMI Patients
NCT03609346 ·Status: COMPLETED
-
Post-Market Registry to Evaluate the Safety and Efficacy of the The SUPRAFLEX CRUZ™ Sirolimus Eluting Coronary Stent System in the Treatment of an Octo- and Nonagenerian All-Comer Patient Cohort With Coronary Artery Disease - the Cruz Senior Study
NCT04612179 ·Status: COMPLETED
-
Biofreedom Stent in All Comer Population
NCT02858739 ·Status: COMPLETED
-
BIOFLOW-china Post-marketing Study (BIOTRONIK)
NCT05667285 ·Status: TERMINATED
-
Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent
NCT01879358 ·Status: UNKNOWN ·Phase: NA
-
Genoss DES Prospective Multicenter Registry
NCT03045913 ·Status: COMPLETED
-
The SORT OUT IX STEMI OCT Trial
NCT02915107 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Biodegradable Stents: Orsiro and BioMatrix
NCT02084901 ·Status: COMPLETED ·Phase: PHASE4
-
MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy Study
NCT01531725 ·Status: COMPLETED ·Phase: NA
-
Orsiro™ Drug Eluting Stent in Routine Clinical Practice
NCT02039739 ·Status: COMPLETED
-
Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis.
NCT01651390 ·Status: COMPLETED ·Phase: NA
-
Ultrathin DES in Complex PCI Scenarios: the ULTRA a Multicenter Study
NCT05205148 ·Status: UNKNOWN